Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas

Oral Oncology

Volumn 35, Issue 6, 1999, Pages 554-560

  Ueda, Naohiro ^a   Kamata, Nobuyuki ^a   Hayashi, Eiji ^a   Yokoyama, Kazuhiro ^a   Hoteiya, Toshiaki ^a   Nagayama, Masaru ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Anti angiogenic agent; Endothelial cells; Growth inhibition; Oral squamous cell carcinomas; TNP 470

Indexed keywords

FUMAGILLOL CHLOROACETYLCARBAMATE;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUTH CARCINOMA; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SQUAMOUS CELL CARCINOMA;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CYCLOHEXANES; DRUG SCREENING ASSAYS, ANTITUMOR; IMMUNOHISTOCHEMISTRY; MICE; MICE, SCID; MOUTH NEOPLASMS; SESQUITERPENES; TUMOR CELLS, CULTURED;

EID: 0032755253     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(99)00031-7     Document Type: Article

References (30)

1. Bikfalvi A. Significance of angiogenesis in tumour progression and metastasis. European Journal of Cancer. 31A:1995;1101-1104.
2. Castronovo V., Belotti D. TNP-470 (AGM-1470): mechanisms of action and early clinical development. European Journal of Cancer. 32A:1996;2520-2527.
3. Folkman J What is the evidence that tumors are angiogenesis dependent? Journal of National Cancer Institute. 82:1990;4-6.
4. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Harold B., Folkman J. Synthetic analogue of fumagillin that inlibit angiogenesis and tumour growth. Nature. 348:1990;555-557.
5. Folkman J., Shing Y. Angiogenesis. Journal of Biological Chemistry. 267:1992;10931-10934.
6. Pluda J.M. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Seminars in Oncology. 24:1997;203-218.
7. Folkman J. Anti-angiogenesis: new concept for therapy of solid tumors. Annals of Surgery. 175:1972;409-416.
8. Brem H., Folkman J. Inhibition of tumor angiogenesis mediated by cartilage. The Journal of Experimental Medicine. 141:1975;427-439.
9. Seed M.P. Angiogenesis inhibition as a drug target for disease: an update. Experimental Opinion of Investigated Drugs. 5:1997;1617-1637.
10. Voest E.E. Inhibitors of angiogenesis in a clinical perspective. Anti-cancer Drugs. 7:1996;723-727.
11. Kudelkam A.P., Verschragen C.F., Loyer E. Complete remission of metastastic cervical cancer with the angiogenesis inhibitor TNP-470. The New England Journal of Medicine. 338:1998;991-992.
12. Gleich L.L., Zimmerman N., Wang Y.O., Gluckman J.L. Angiogenic inhibition for the treatment of head and neck cancer. Anticancer Research. 18:1998;2607-2609.
13. Alberda S.M., Muller W.A., Buck C.A., Newman P.J. Molecular cellular properties of PECAM-1 (endoCAM/CD3l): a novel vascular cell-cell adhesion molecule. The Journal of Cell Biology. 114:1991;1059-1068.
14. Kamata N., Chida K., Rikimaru K., Horikoshi M., Enomoto S., Kuroki T. Growth-inhibitory effects of epidermal growth factor and overexpression of its receptors on human squamous cell carcinomas in culture. Cancer Research. 46:1986;1648-1653.
15. Hayashi E., Rikimaru K., Satomura K., Nakano K., Hoteiya T., Kurasato T., Nagayama M. Establishment and characterization of four human oral cell lines. Japanase Journal of Stomatological Society. 44:1995;47-54. (in Japanese).
16. Hayashi E., Rikimaru K., Nagayama M. Simultaneous production of G- and M-CSF by an oral cancer cell line and the synergistic effects on associated leucocytosis. Oral Oncology, European Journal of Cancer. 31B:1995;323-327.
17. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. The New England Journal of Medicine. 324:1991;1-8.
18. Yamaoka M., Yamamoto T., Masaki T., Ikeyama S., Sudo K., Fujita T. Inhibition of tumor growth and metastasis of rodent tumors by the angiogenisis inhibitor O-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). Cancer Research. 53:1993;4262-4267.
19. Yamaoka M., Yamamoto T., Ikeyama S., Sudo K., Fujita T. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumor growth of hormone-independent human breast and prostate carcinoma cell lines. Cancer Research. 53:1993;5233-5236.
20. Yanase T., Tamura M., Fujita K., Kodama S., Tanaka K. Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vivo and in vitro. Cancer Research. 53:1993;2566-2570.
21. Hori K., Li H-C., Saito S., Sato Y. Increased growth and incidence of lymph node metastases due to the angiogenesis inhibitor AGM-1470. British Journal of Cancer. 75:1997;1730-1734.
22. Ohta Y., Watanabe Y., Tabata T., Oda M., Hayashi Y., Endo Y., Tanaka M, Sasaki T. Inhibition of lymph node metastasis by an anti-angiogenesis agent, TNP-470. British Journal of Cancer. 75:1997;512-515.
23. Kato T., Sato K., Kakinuma H., Matsuda Y. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Research. 54:1994;5143-5147.
24. Takamiya Y., Friedlander R.M., Brem H., Martuza R.L. Inhibition of angiogenesis and growth of human nerve-sheath tumors by AGM-1470. Journal of Neurosurgery. 78:1993;470-476.
25. Kamei S., Okada H., Inoue Y., Yoshioka T., Ogawa Y., Toguchi H. Antitumor effects of angiogenesis inhibitor TNP-470 in microspheres and oil solution. The Journal of Pharmacology and Experimental Therapeutics. 264:1993;469-474.
26. Tanaka T., Konno H., Matsuda I., Nakamura S., Baba S. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470. Cancer Research. 55:1995;836-839.
27. Kusaka M., Sudo K., Fujita T., Marui S., Itoh F., Ingber D., Folkman J. Potently anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochemical and Biophysical Research Communications. 174:1991;1070-1076.
28. Kusaka M., Sudo K., Matsutani E., Kozai Y., Marui S., Fujita T., Ingber D., Folkman J. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470. British Journal of Cancer. 69:1994;212-216.
29. Abe J., Zhou W., Takuwa N., Taguchi J., Kurokawa K., Kumada M., Takuwa Y. A fumagillin derivative angiogenesis inhibitor, AGM-1470, inhibits activation of cyclin-dependent kinases and phosphorylation of retinoblastoma gene product but not protein tyrosyl phosphorylation or protooncogene expression in vascular endothelial cells. Cancer Reseach. 54:1994;3407-3412.
30. Hori A., Ikeyama S., Sudo K Suppression of cyclin D1 mRNA expression by the angiogenesis inhibitor TNP-470 (AGM-1470) in vascular endothelial cells. Biochemical and Biophysical Research Communications. 204:1994;1067-1073.